©2024 Stanford Medicine
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
Not Recruiting
Trial ID: NCT02175745
Purpose
To evaluate 18F-FDOPA PET obtained from PET/CT or PET/MRI imaging in patients with newly diagnosed or recurrent gliomas.
Official Title
18F-FDOPA PET/CT or PET/MRI in Patients With Gliomas
Stanford Investigator(s)
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
Lawrence Recht, MD
Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery
Eligibility
Inclusion Criteria:
* Greater than 15 year-old at the time of radiotracer administration
* Provides written informed consent
* Suspected new diagnosis or suspected recurrence of glioma
* Able to remain still for duration of each imaging procedure (about 20 minutes)
Exclusion Criteria:
* Less than 15 year-old at the time of radiotracer administra
* Unable to provide informed consent
* Inability to lie still for the entire imaging time
* Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)
* Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance
Intervention(s):
procedure: magnetic resonance imaging
drug: 18F-fluoro-dihydroxyphenylalanine
procedure: Positron emission tomography (PET)
procedure: Computed tomography (CT)
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Andrei Iagaru
650-736-2859